The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation to 47 new medicines in 2026, according to the MHRA’s annual report.
Key takeaways
- 47 new medicines received UK marketing authorisation in 2026 according to MHRA data
Medicine Approvals Granted by MHRA
The MHRA processed marketing authorisation applications for various therapeutic areas throughout 2026.
47 marketing authorisations were granted in 2026.
— MHRA Annual Report (UK Government Publications, 2026)
What this means
Frequently asked questions
What is a marketing authorisation?
A marketing authorisation is official permission from the MHRA allowing a pharmaceutical company to market a medicine in the UK.
Who grants marketing authorisations in the UK?
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for granting marketing authorisations in the UK.
The 47 marketing authorisations granted in 2026 represent the continued operation of the UK’s pharmaceutical regulatory system.
Source: Marketing authorisations Granted in 2026
Was this article helpful?
100% of readers found this helpful (1 votes)
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
